The College of Nursing, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
First Affiliated Hospital, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
BMJ Open. 2022 Aug 25;12(8):e058557. doi: 10.1136/bmjopen-2021-058557.
The organisational silence of nursing teams has received increasing attention from managers. Chinese nurses have a relatively high score for organisational silence, and male nurses score higher than female nurses. Lack of professional empathy, high pressure in the work environment, and traditional Chinese cultural factors suggest that Chinese male nurses' experiences of and reasons for organisational silence are complex and unique. Taking male nurses in the emergency department as an example, this study explores the experience and meaning of male nurses' organisational silence and provides ideas for nursing managers to understand the silence of male nurses.
An interpretative phenomenological approach underpins the study design. In this study, the purposive sampling method will be used to select male nurses who meet the inclusion criteria with maximum differentiation as a strategy. Face-to-face semistructured interviews and Van Manen analysis methods will be used for data collection and analysis.
The study was approved by the Ethics Committee of the First Affiliated Hospital of Zhejiang Chinese Medical University (ethical approval ID: 2019-KL-036-01). Participants will provide informed consent, will be able to withdraw at any time and will have their contributions kept confidential. The findings of the study will be shared with relevant stakeholders and disseminated in conference presentations and journal publications.
Chinese Clinical Trial Registry (ChiCTR2100047057).
护理团队的组织沉默引起了管理者的广泛关注。中国护士的组织沉默得分相对较高，男护士的得分高于女护士。缺乏专业同理心、工作环境压力大以及传统的中国文化因素表明，中国男护士在组织沉默方面的经历和原因是复杂而独特的。本研究以急诊科男护士为例，探讨男护士组织沉默的体验和意义，为护理管理者了解男护士的沉默提供思路。
本研究的设计基于解释现象学方法。在这项研究中，将采用目的性抽样方法，以最大差异策略选择符合纳入标准的男护士。将采用面对面半结构式访谈和范梅南分析方法进行数据收集和分析。
本研究已获得浙江中医药大学第一附属医院伦理委员会的批准（伦理审批号：2019-KL-036-01）。参与者将提供知情同意，随时可以退出，其贡献将保密。研究结果将与相关利益相关者分享，并通过会议演讲和期刊发表进行传播。
中国临床试验注册中心（ChiCTR2100047057）。
